Yubo International Biotech Limited (YBGJ)
OTCMKTS · Delayed Price · Currency is USD
0.0084
0.00 (0.00%)
Jun 1, 2026, 4:00 PM EST
YBGJ Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 0.01 | 0.01 | 0 | 0.6 | 0.1 | 1.24 | |
Revenue Growth (YoY) | - | 255.99% | -99.43% | 479.84% | -91.62% | -8.09% |
Cost of Revenue | 0 | 0 | 0.21 | 0.19 | 0.05 | 0.42 |
Gross Profit | 0.01 | 0.01 | -0.21 | 0.42 | 0.05 | 0.82 |
Selling, General & Admin | 0.72 | 0.88 | 1.25 | 1.11 | 1.05 | 1.49 |
Amortization of Goodwill & Intangibles | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Other Operating Expenses | 0.13 | 0.14 | 0.34 | 0.32 | 0.23 | 0.8 |
Operating Expenses | 1.02 | 1.2 | 1.77 | 1.61 | 1.26 | 2.36 |
Operating Income | -1.01 | -1.19 | -1.98 | -1.19 | -1.21 | -1.54 |
Interest Expense | -0.01 | -0 | - | -0 | - | - |
Interest & Investment Income | - | - | 0 | - | 0 | 0 |
Pretax Income | -1.02 | -1.19 | -1.98 | -1.2 | -1.2 | -1.54 |
Earnings From Continuing Operations | -1.02 | -1.19 | -1.98 | -1.2 | -1.2 | -1.54 |
Minority Interest in Earnings | 0.1 | 0.11 | 0.21 | - | - | - |
Net Income | -0.92 | -1.08 | -1.78 | -1.2 | -1.2 | -1.54 |
Net Income to Common | -0.92 | -1.08 | -1.78 | -1.2 | -1.2 | -1.54 |
Shares Outstanding (Basic) | 152 | 140 | 120 | 12 | 119 | 118 |
Shares Outstanding (Diluted) | 152 | 140 | 120 | 12 | 119 | 118 |
Shares Change (YoY) | 3.76% | 16.55% | 900.00% | -89.91% | 0.50% | 1.94% |
EPS (Basic) | -0.01 | -0.01 | -0.01 | -0.10 | -0.01 | -0.01 |
EPS (Diluted) | -0.01 | -0.01 | -0.01 | -0.10 | -0.01 | -0.01 |
Free Cash Flow | -0.65 | -0.84 | -1.34 | -0.74 | -0.6 | -1.59 |
Free Cash Flow Per Share | -0.00 | -0.01 | -0.01 | -0.06 | -0.01 | -0.01 |
Gross Margin | 66.10% | 66.10% | - | 69.32% | 50.49% | 65.95% |
Operating Margin | -8173.49% | -9614.64% | -57113.60% | -197.58% | -1155.72% | -123.99% |
Profit Margin | -7417.03% | -8736.73% | -51161.47% | -197.64% | -1155.50% | -123.95% |
Free Cash Flow Margin | -5275.88% | -6822.65% | -38551.27% | -122.21% | -576.27% | -127.42% |
EBITDA | -0.85 | -1.01 | -1.8 | -1 | -1.18 | -1.52 |
EBITDA Margin | - | - | - | -166.15% | - | -122.27% |
D&A For EBITDA | 0.16 | 0.18 | 0.18 | 0.19 | 0.03 | 0.02 |
EBIT | -1.01 | -1.19 | -1.98 | -1.19 | -1.21 | -1.54 |
EBIT Margin | - | - | - | -197.58% | - | -123.99% |